{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-127626","form_type":"8-K","ticker":"ANVS","cik":"0001477845","company_name":"Annovis Bio, Inc.","filed_at":"2024-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.549887+00:00","generated_at":"2026-05-29T04:42:01.703624+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"low","headline":"Annovis Bio presents investor deck on path to NDA for Alzheimer's and Parkinson's","bullets":["Presentation on December 11, 2024 outlines development path to NDA for Alzheimer's and Parkinson's.","Deck used during live webcast; full content not available in this filing excerpt.","No specific clinical data, financial figures, or milestone dates disclosed in the provided text."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-127626","json":"https://secwatch.observer/filing/0001104659-24-127626.json","markdown":"https://secwatch.observer/filing/0001104659-24-127626.md","text":"https://secwatch.observer/filing/0001104659-24-127626.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924127626/0001104659-24-127626-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924127626/tm2430782d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:42:01.703624+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}